Dr. Christopher Winter, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,729 | 132 | 96.2% |
| Education | $108.37 | 2 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $413.80 | 29 | $0 (2024) |
| PFIZER INC. | $243.99 | 14 | $0 (2024) |
| Boston Scientific Corporation | $212.52 | 3 | $0 (2020) |
| KARL STORZ Endoscopy-America | $195.19 | 4 | $0 (2018) |
| PROCEPT BioRobotics Corporation | $189.08 | 1 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $185.91 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $182.19 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $178.64 | 9 | $0 (2024) |
| ABBVIE INC. | $135.12 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $123.58 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.86 | 23 | Sumitomo Pharma America, Inc. ($79.23) |
| 2023 | $840.79 | 35 | PROCEPT BioRobotics Corporation ($189.08) |
| 2022 | $325.79 | 19 | PFIZER INC. ($100.49) |
| 2021 | $13.40 | 1 | PFIZER INC. ($13.40) |
| 2020 | $165.28 | 5 | Boston Scientific Corporation ($127.02) |
| 2019 | $468.18 | 33 | Astellas Pharma US Inc ($253.96) |
| 2018 | $548.45 | 18 | KARL STORZ Endoscopy-America ($195.19) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Sagent Pharmaceuticals | Glydo (Drug) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Topical local anesthetic | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 10/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $32.18 | General |
| 09/09/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Oncology | ||||||
| 06/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Energy | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: HORMONE THERAPY | ||||||
| 04/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Oncology | ||||||
| 03/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Oncology | ||||||
| 03/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: HORMONE THERAPY | ||||||
| 02/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Oncology | ||||||
| 02/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: HORMONE THERAPY | ||||||
| 01/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: HORMONE THERAPY | ||||||
| 12/07/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 890 | 4,846 | $179,062 | $52,290 |
| 2022 | 12 | 818 | 3,796 | $144,841 | $43,480 |
| 2021 | 29 | 1,419 | 6,433 | $322,843 | $119,957 |
| 2020 | 27 | 1,137 | 5,896 | $269,837 | $67,602 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 240 | $53,760 | $20,163 | 37.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 31 | 45 | $33,750 | $7,758 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 113 | $16,950 | $6,469 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $21,460 | $6,376 | 29.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 18 | 19 | $17,214 | $3,662 | 21.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 11 | 12 | $9,600 | $1,855 | 19.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 15 | $5,175 | $1,533 | 29.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 23 | $6,624 | $1,058 | 16.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 17 | 18 | $4,140 | $773.40 | 18.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 129 | 174 | $2,262 | $538.03 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 179 | 223 | $1,784 | $486.54 | 27.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 58 | 65 | $2,665 | $485.46 | 18.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 30 | 3,805 | $1,522 | $444.54 | 29.2% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 18 | 20 | $1,340 | $389.49 | 29.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 15 | 16 | $816.00 | $298.24 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 199 | $44,576 | $16,148 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 136 | $20,400 | $8,121 | 39.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 30 | 39 | $29,250 | $6,795 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $19,610 | $5,951 | 30.3% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2022 | 17 | 17 | $15,402 | $3,154 | 20.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 21 | 24 | $5,520 | $841.62 | 15.2% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 23 | 27 | $1,809 | $576.83 | 31.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 128 | 170 | $2,210 | $518.29 | 23.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 166 | 198 | $1,584 | $434.36 | 27.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 53 | 64 | $2,624 | $430.94 | 16.4% |
About Dr. Christopher Winter, MD
Dr. Christopher Winter, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982043824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Winter, MD has received a total of $2,838 in payments from pharmaceutical and medical device companies, with $475.86 received in 2024. These payments were reported across 134 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,729).
As a Medicare-enrolled provider, Winter has provided services to 4,264 Medicare beneficiaries, totaling 20,971 services with total Medicare billing of $283,329. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Greensboro, NC
- Active Since 06/24/2013
- Last Updated 05/08/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982043824
Products in Payments
- XTANDI (Drug) $338.33
- MYRBETRIQ (Drug) $195.18
- AQUABEAM ROBOTIC SYSTEM (Device) $189.08
- Nubeqa (Drug) $156.99
- KEYTRUDA (Biological) $156.54
- ORGOVYX (Drug) $155.05
- 09 PROMO FLEX-X FLEX URETEROSCOPE, 7.5F (Device) $137.77
- REZUM (Device) $127.02
- INTERSTIM (Device) $108.42
- BOTOX (Biological) $101.37
- JELMYTO (Drug) $87.64
- ERECTILE DYSFUNCTION (Device) $85.50
- ERLEADA (Drug) $64.49
- Axumin (Drug) $59.66
- XIAFLEX (Biological) $55.19
- LYNPARZA (Drug) $46.34
- GEMTESA (Drug) $43.12
- AVEED (Biological) $41.38
- PROVENGE (Drug) $40.38
- LUPRON DEPOT (Drug) $33.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Greensboro
Peter Arnold, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $223,872
Dr. Christopher White, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,427
Jon Mugweru, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $7,923
Eugene Bell, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,328
Dr. Matthew Gay, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,240
Stephanie Wolfe, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,597